CLOT-VENUS substudy identifies inflammatory biomarkers predicting outcomes in acute cerebral venous thrombosis, suggesting avenues for early risk assessment.
Elevated admission levels of neutrophil-to-lymphocyte ratio, PLR, monocyte-to-lymphocyte ratio, and SII are independently associated with poor discharge and 6-month outcomes in patients with acute cerebral venous thrombosis. These accessible biomarkers may aid early risk stratification. Further studies should validate and explore its usefulness in clinical models for personalized management.
No takes yet. Share an insight, caveat, or question.
Cruz-Criollo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: